Trial intelligence / Profile preview

Aricept in Memory-Impaired MS Patients

NCT00315367Phase 4Completed

Sponsor
Neurognostics
Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of donepezil in multiple sclerosis (MS), sponsored by Neurognostics. Started Sep 2004; status: completed.

02

Drugs

donepezil
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on NCT00315367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00315367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call